Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose radiolabeled ralmitaront mass balance and pharmacokinetics study in healthy male volunteers
NL-OMON51079Active, not recruiting
- Sponsor
- Roche
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of ralmitaront, sponsored by Roche. Started Mar 2021; status: active, not recruiting.
02
Drugs
ralmitaront
Beyond the preview
Go deeper on NL-OMON51079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51079.